Multiple Bowel Perforations Complicating Imatinib Treatment for Advanced Gastrointestinal Stromal Tumor

Journal of the American College of Surgeons

Volumn 206, Issue 2, 2008, Pages 386-387

  Chiarugi, Massimo ^a   Galatioto, Christian ^a   Lippolis, Piero V ^a   Seccia, Massimo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ABDOMINAL PAIN; ABDOMINAL SCINTISCANNING; ADVANCED CANCER; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEVER; GASTROINTESTINAL STROMAL TUMOR; HUMAN; INTESTINE PERFORATION; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VOMITING;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINAL PERFORATION; PIPERAZINES; PYRIMIDINES;

EID: 38349178753     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.04.048     Document Type: Article

References (2)

1. Demetri G.D., von Meheren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
2. Van Oosterom A.T., Judson I., Verweij J., et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358 (2001) 1421-1423